(THE CONVERSATION) As research into psychedelics and their medical uses makes a comeback, scientists are having to deal with the legacy – both scientific and social – of a 40-year nearly total freeze ...

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...

Yet, this lack of bespoke options is more or less the reality of medicine today. Despite the many biological differences between people of different genders, races, ages and life histories, chances ...

When the heart skips a beat: research from discovery science through to benefits for patients and the NHS. Throughout the ...

I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in ...

The clinical practice update offers 12 “best practice advice” statements on POEM to treat achalasia and other esophageal ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

A man convicted of killing two people in Bell County is set to be executed on Thursday, Feb. 12. Richard Lee Tabler was ...

While researchers are grateful they can offer patients one of the two approved stabilizers, better therapeutics are still ...

The Independent Data Monitoring Committee met this week on February 10, 2025 to evaluate the unblinded safety Phase 2b QUALITY data and recommended to continue the QUALITY extension study as designed- ...

Compared with a placebo injection, platelet-rich plasma injections yielded similar outcomes at 1 year for patients with ...

The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects.